You are here: Industry Insights > Liver Disease

News List

Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase prnasia
December 27, 2021
Laekna was invited by NewYorkBIO and the New York Stock Exchange (NYSE) to present, as an emerging biotech company at the "Emerging Company Showcase" that was held earlier this month in New York.
Ambys raises funding to expand liver cell therapy production capabilities Pharmaceutical-Business-Review
December 23, 2021
This brings the company’s total Series A funding raised to $107m.
Liver Disease Patients Struggle with Healthy Habits During the Covid-19 Pandemic, Data Show prnewswire
September 23, 2021
Nutrition and lifestyle are considered the most important factors for liver health. However, when the Covid-19 pandemic disrupted our daily lives, liver disease patients experienced a downturn in their healthy habits.
Albireo’s Bylvay approved in EU and US for rare paediatric liver disease pharmatimes
July 23, 2021
Albireo Pharma’s Bylvay has received approval on both sides of the Atlantic this week, scoring authorisation in the EU and US for the treatment of all subtypes of progressive familial intrahepatic cholestasis (PFIC).
SMIC Liver Transplant Program's Ninth Donation Raised Over 33 Million Yuan prnasia
June 17, 2021
On June 16th, Semiconductor Manufacturing International Corporation held its 9th SMIC Liver Transplant Program Donation Ceremony at Shanghai Jiao Tong University School of Medicine's Renji Hospital.
Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease expresspharma
December 31, 2020
Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH.
Owlstone Medical’s breath biopsy test improves detection of liver disease pharmatimes
September 27, 2020
Cambridge-based Owlstone Medical has announced new results from a study of its breath-based diagnostic test for liver disease, including Nonalcoholic Fatty Liver Disease (NAFLD) and associated Nonalcoholic steatohepatitis (NASH).
Engitix signs drug discovery and licensing deal with Takeda pharmaceutical-technology
August 27, 2020
UK-based biotechnology firm Engitix has signed a licensing and collaboration agreement with Takeda Pharmaceutical for the discovery and development of new drugs to treat fibrotic liver diseases.
Partnership gets £4.4m gov grant for better liver diagnostics pharmatimes
July 03, 2020
Perspectum has been awarded a multimillion pound UK government research grant (UKRI) with partners for the development of new technology to help save patients’ lives by diagnosing liver disease earlier.
Alnylam and Dicerna to develop liver disease therapies pharmaceutical-technology
April 08, 2020
Alnylam Pharmaceuticals has partnered with Dicerna Pharmaceuticals to develop and commercialise ribonucleic acid interference (RNAi) therapies to treat alpha-1 antitrypsin (A1AT) deficiency-associated liver disease.

Previous page 1 2 3 Next page